Industry watchers were worried about neglect for Bayer’s healthcare division when the company chased down its megamerger with agrochemical giant Monsanto. But that deal hasn’t even closed yet, and healthcare sales are already showing cause for concern.Original Article
Turns out, Bayer HealthCare’s faltering even before Monsanto enters the fold
